Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments

nsolidated Statements of Operations (In thousands, except per share amounts)Three months endedYear endedDecember 31,December 31,2010200920102009(unaudited)(Note)RevenuesManufacturing services

$  1,799$  1,916$  7,057$  6,579Collaborative agreements

2,2137669,5563,808  Total revenues

4,0122,68216,61310,387Operating ExpensesCost of manufacturing services

2,1051,8347,4146,536Research and development

16,48821,18775,459110,159General and administrative

7,3006,52227,93625,247Restructuring charges

———3,324Amortization of acquired technology & other intangibles

5501,7872,1593,508  Total operating expenses

26,44331,330112,968148,774Interest and Other Income (Expense)Interest income

131398469689Interest expense

(5,483)(7,727)(21,681)(18,718)Gain (Loss) from valuation of derivative liabilities

(486)5,0734,3715,418Loss on extinguishment of debt


281,1321,016273  Total interest and other expense, net

(5,810)(1,124)(28,179)(14,817)Net loss

$(28,241)$(29,772)$(124,534)$(153,204)Net loss per share, basic & diluted

$(0.23)$(0.32)$(1.14)$(1.82)Shares used in calculating net loss per share, basic & diluted

121,41592,719109,57384,341Note: The Condensed Consolidated Statements of Operations has been derived from the audited financial statements for the year ended December 31, 2009 and from the unaudited financial statements for the year ended December 31, 2010.Arena Pharmaceuticals, Inc.Condensed Consolidated Balance Sheet Data(In thousands)December 31, 2010December 31, 2009**Assets  Cash, cash equivalents & short-term investments

$ 150,669$ 115,449  Accounts receivable

3,4991,415  Other current assets

2,6384,409  Land, property & equipment, net

91,53395,445 &#

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
(Date:10/8/2015)... 8, 2015 " Biomedical Refrigerators ... Trends and Forecast 2014 - 2022 " , the ... billion in 2013 and is anticipated to expand at a ... 4.00 billion in 2022. --> " Biomedical ... Growth, Trends and Forecast 2014 - 2022 " , ...
(Date:10/8/2015)... DUBLIN , Oct. 08 2015 /PRNewswire/ ... announced the addition of the "Natural ... Life Sciences Industry by Type (Rule-Based, Statistical, ... Europe, Asia-Pacific, Middle East and Africa, Latin ... report to their offering. --> ...
(Date:10/8/2015)... -- Celtaxsys, a clinical stage drug development company focused on ... announced today the commencement of the US arm of ... compound, acebilustat, in patients with cystic fibrosis (CF). The ... the United States and European ... early 2016. This landmark clinical trial testing once-daily oral ...
Breaking Medicine Technology:
... July 20, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... results for the second quarter 2011 prior to the open ... John H. Johnson, Chief Executive Officer and President, and ... host an investment community conference call beginning at 9:00 a.m. ...
... LOUISVILLE, Ky., July 20, 2011 BellaNovus Development ... today announced its launch of the Ouchless™ Needle ... an innovative alternative to numbing creams and ice ... cosmetic injectables, such as Botox® and dermal fillers. ...
Cached Medicine Technology:
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... A variety of race options will be ... of Co-occurring Disorders on Sunday, October 18, at Al Lopez Park, 4810 North Himes Avenue, ... will include the choice of a 5K run or walk and a one-mile walk, followed ...
(Date:10/9/2015)... AZ (PRWEB) , ... October 09, 2015 , ... Dignity ... Health Arizona General Hospital Emergency Room – Chandler–McQueen opening later this month. ... opened earlier this year in the West Valley. , “Dr. Morro is an ...
(Date:10/9/2015)... ... October 09, 2015 , ... Safe Space, a non-profit ... communities, launched a new website to mark Domestic Violence Awareness Month. , ... help immediately, whether through an emergency hotline, support group, or shelter. The revamped ...
(Date:10/9/2015)... Abilene, Texas (PRWEB) , ... October 09, 2015 , ... ... new article this week that takes the subject of health care back to the ... too many sicknesses that are able to be prevented if only biblical laws were ...
(Date:10/9/2015)... ... 09, 2015 , ... Bag Tags Inc. will provide custom ... media at the annual IRONMAN World Championship in Kailua-Kona, Hawaii, this Saturday, ... has taken place in Hawaii every year since 1978. , As part of ...
Breaking Medicine News(10 mins):
... certain biomarker in the blood may predict the risk of ... //, according to a new study. ,Researchers conducted a ... (PIGF) can predict risk for death or non-fatal heart attack ... of the vascular growth factor family and it acts as ...
... New research reveals why certain people are at an ... shows individuals who have // three or more traits ... dying from a heart problem. ,Metabolic syndrome is ... tissue in and around the abdomen, blood-fat disorders, insulin ...
... more common in developed countries and has increased over the ... // study environmental factors and diet may be the reason ... to a new study. ,In the study involving more ... children from Hong Kong had a significantly higher prevalence of ...
... 40 are five-times more likely to suffer a heart attack ... disease cases of study participants between the ages of 33 ... and 4,047 were women. ,Results showed 80 percent of ... the ages of 35 and 39.In the study, smoking also ...
... them what type of bed is best for their lower ... to support their answers. Therefore, researchers in Spain conducted a ... medium-firm mattress when it comes to lower back pain. ... mattresses replaced with either a firm or a medium-firm mattress. ...
... reach age 40 can expect to develop an irregular heartbeat, ... -- or atrial fibrillation -- is a major risk factor ... which can lead to pooling and clotting of blood. ... brain, a stroke results. ,In a large clinical trial ...
Cached Medicine News:
... EX is a rigid gas lens with ... specific characteristics as hard contact lens, it ... excellent performance against astigmatism. The key feature ... combination of fluoromethacrylate, Siloxanylmethacrylate and methacrylic acid, ...
Achievement, available exclusively from Art Optical, is a unique RGP lens design with a patented junctionless back surface and a controlled edge lift....
... a simultaneous vision lens with ... a series of front and ... Gp delivers up to +3.00 ... multi-aspheric center-distance design works in ...
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach....
Medicine Products: